Orbit International Power Group Reports October Bookings of About $1.7 Million
Bitget2026/11/06 13:45- Orbit International's power group booked approximately $1.7 million in October 2026, its fourth straight month above $1 million.
- Bookings through October 31 rose 42.9% from the comparable prior-year period, exceeding the full-year 2025 total.
- Year-to-date VPX power supply bookings exceeded $5 million for the first time, up 94.6% from the prior-year period.
- October orders included approximately $775,000 in VPX power supplies from a large defense customer.
- Deliveries under the October contracts have begun, with completion expected in the first quarter of 2028.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.